Your browser doesn't support javascript.
loading
Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity.
Abbas, Abdul Baset; Lin, Bingjing; Liu, Chen; Morshed, Arwa; Hu, Jialiang; Xu, Hanmei.
Afiliación
  • Abbas AB; The Engineering Research Center of Synthetic Polypeptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing 210009, China. abduabbas04@gmail.com.
  • Lin B; Department of Medical Microbiology, Faculty of Sciences, Ibb University, Ibb City 70270, Yemen. abduabbas04@gmail.com.
  • Liu C; The Engineering Research Center of Synthetic Polypeptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing 210009, China. 1621030498@stu.cpu.edu.cn.
  • Morshed A; The Engineering Research Center of Synthetic Polypeptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing 210009, China. hsdalan@163.com.
  • Hu J; The Engineering Research Center of Synthetic Polypeptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing 210009, China. arw34129@gmail.com.
  • Xu H; Department of Medical Microbiology, Faculty of Sciences, Ibb University, Ibb City 70270, Yemen. arw34129@gmail.com.
Int J Mol Sci ; 20(3)2019 Jan 29.
Article en En | MEDLINE | ID: mdl-30699956
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: China